Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence

The imbalance between pro- and anti-inflammatory immune responses mediated by Th17 and Treg cells is deeply involved in the development and progression of inflammation in chronic obstructive pulmonary disease (COPD). Several clinical and experimental studies have described the Th17/Treg imbalance in...

Full description

Bibliographic Details
Main Authors: Juliana Dias Lourenço, Juliana Tiyaki Ito, Milton de Arruda Martins, Iolanda de Fátima Lopes Calvo Tibério, Fernanda Degobbi Tenorio Quirino dos Santos Lopes
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.804919/full
_version_ 1830162665600712704
author Juliana Dias Lourenço
Juliana Tiyaki Ito
Milton de Arruda Martins
Iolanda de Fátima Lopes Calvo Tibério
Fernanda Degobbi Tenorio Quirino dos Santos Lopes
author_facet Juliana Dias Lourenço
Juliana Tiyaki Ito
Milton de Arruda Martins
Iolanda de Fátima Lopes Calvo Tibério
Fernanda Degobbi Tenorio Quirino dos Santos Lopes
author_sort Juliana Dias Lourenço
collection DOAJ
description The imbalance between pro- and anti-inflammatory immune responses mediated by Th17 and Treg cells is deeply involved in the development and progression of inflammation in chronic obstructive pulmonary disease (COPD). Several clinical and experimental studies have described the Th17/Treg imbalance in COPD progression. Due to its importance, many studies have also evaluated the effect of different treatments targeting Th17/Treg cells. However, discrepant results have been observed among different lung compartments, different COPD stages or local and systemic markers. Thus, the data must be carefully examined. In this context, this review explores and summarizes the recent outcomes of Th17/Treg imbalance in COPD development and progression in clinical, experimental and in vitro studies.
first_indexed 2024-12-17T15:23:08Z
format Article
id doaj.art-baae9f5bfeba4b3a8866c52baf74ea5c
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-17T15:23:08Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-baae9f5bfeba4b3a8866c52baf74ea5c2022-12-21T21:43:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-12-011210.3389/fimmu.2021.804919804919Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental EvidenceJuliana Dias LourençoJuliana Tiyaki ItoMilton de Arruda MartinsIolanda de Fátima Lopes Calvo TibérioFernanda Degobbi Tenorio Quirino dos Santos LopesThe imbalance between pro- and anti-inflammatory immune responses mediated by Th17 and Treg cells is deeply involved in the development and progression of inflammation in chronic obstructive pulmonary disease (COPD). Several clinical and experimental studies have described the Th17/Treg imbalance in COPD progression. Due to its importance, many studies have also evaluated the effect of different treatments targeting Th17/Treg cells. However, discrepant results have been observed among different lung compartments, different COPD stages or local and systemic markers. Thus, the data must be carefully examined. In this context, this review explores and summarizes the recent outcomes of Th17/Treg imbalance in COPD development and progression in clinical, experimental and in vitro studies.https://www.frontiersin.org/articles/10.3389/fimmu.2021.804919/fullTh17 cells (Th17)regulatory T cell (Treg)Th17/Treg imbalanceCOPDimmune response
spellingShingle Juliana Dias Lourenço
Juliana Tiyaki Ito
Milton de Arruda Martins
Iolanda de Fátima Lopes Calvo Tibério
Fernanda Degobbi Tenorio Quirino dos Santos Lopes
Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
Frontiers in Immunology
Th17 cells (Th17)
regulatory T cell (Treg)
Th17/Treg imbalance
COPD
immune response
title Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
title_full Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
title_fullStr Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
title_full_unstemmed Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
title_short Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
title_sort th17 treg imbalance in chronic obstructive pulmonary disease clinical and experimental evidence
topic Th17 cells (Th17)
regulatory T cell (Treg)
Th17/Treg imbalance
COPD
immune response
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.804919/full
work_keys_str_mv AT julianadiaslourenco th17tregimbalanceinchronicobstructivepulmonarydiseaseclinicalandexperimentalevidence
AT julianatiyakiito th17tregimbalanceinchronicobstructivepulmonarydiseaseclinicalandexperimentalevidence
AT miltondearrudamartins th17tregimbalanceinchronicobstructivepulmonarydiseaseclinicalandexperimentalevidence
AT iolandadefatimalopescalvotiberio th17tregimbalanceinchronicobstructivepulmonarydiseaseclinicalandexperimentalevidence
AT fernandadegobbitenorioquirinodossantoslopes th17tregimbalanceinchronicobstructivepulmonarydiseaseclinicalandexperimentalevidence